Investors

Ahren Innovation Capital
24Haymarket
DD - Copy
Dr. Darrin M. Disley, OBE

If you have ambition to back a game-changing technology platform and proven management team who aspire to become leading players in the global cell therapy market, we would like to hear from you ahead of our Series A investment round.